C1QTNF9B: A Protein Involved in T Cell Signaling and Cell-cell Adhesion

Target Name: C1QTNF9B

NCBI ID: G387911

C1QTNF9B

C1QTNF9B: A Protein Involved in T Cell Signaling and Cell-cell Adhesion

C1QTNF9B (CTRP9B) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the C1 queue family of transmembrane proteins, which are known for their ability to form tight junctions between epithelial cells. C1QTNF9B is also known as TSPO2, and has been shown to play a role in the regulation of intracellular signaling pathways, including the T cell signaling pathway.

C1QTNF9B is a 21-kDa protein that consists of 106 amino acid residues. It has a characteristic transmembrane domain, which is responsible for its ability to form tight junctions between epithelial cells. This domain is composed of a variety of conserved sequence elements, including a long amino acid sequence known as \"helices,\" which are believed to play a role in the stability and structure of the protein.

In addition to its transmembrane domain, C1QTNF9B also has a cytoplasmic tail that is involved in its localization to various cell types. This tail is composed of a variety of cysteine 鈥嬧?媟esidues, which are known for their ability to interact with other proteins and to play a role in the regulation of cellular signaling pathways.

C1QTNF9B has been shown to play a role in the regulation of intracellular signaling pathways, including the T cell signaling pathway. This pathway is involved in the regulation of many cellular processes, including cell growth, differentiation, and immune response. C1QTNF9B has been shown to be involved in the regulation of the expression and activity of several T cell receptor genes, including CD47, CTLA-4, and PD-1.

In addition to its role in the T cell signaling pathway, C1QTNF9B has also been shown to play a role in the regulation of other cellular processes, including cell adhesion, migration, and survival. This protein has been shown to be involved in the regulation of tight junction formation and the maintenance of cell-cell adhesion, which are important for the regulation of cellular behavior and the development of cancer.

C1QTNF9B is also known as TSPO2, and has been shown to play a role in the regulation of the blood-brain barrier. This barrier is responsible for the regulation of the exchange of nutrients, drugs, and other substances between the brain and the bloodstream, and is thought to play a role in the development of certain neurological disorders. C1QTNF9B has been shown to be involved in the regulation of the formation and function of the blood-brain barrier, which may have implications for the development of these disorders.

In conclusion, C1QTNF9B is a protein that is expressed in various tissues of the body and is involved in the regulation of intracellular signaling pathways, including the T cell signaling pathway. It has been shown to play a role in the regulation of cell adhesion, migration , and survival, as well as the regulation of the blood-brain barrier. Based on these findings, C1QTNF9B may be a promising drug target or biomarker for the treatment of a variety of diseases.

Protein Name: C1q And TNF Related 9B

Functions: Probable adipokine. Activates AMPK, AKT, and p44/42 MAPK signaling pathways

The "C1QTNF9B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C1QTNF9B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets